Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417379 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Daniela Kovacs und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, It…. Hauptthemen laut MEDLINE: Endocannabinoids, Neoplasms. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health.
Abstract (Originalsprache)
The endocannabinoid system regulates physiological processes, and the modulation of endogenous endocannabinoid (eCB) levels is an attractive tool to contrast the development of pathological skin conditions including cancers. Inhibiting FAAH (fatty acid amide hydrolase), the degradation enzyme of the endocannabinoid anandamide (AEA) leads to the increase in AEA levels, thus enhancing its biological effects. Here, we evaluated the anticancer property of the FAAH inhibitor URB597, investigating its potential to counteract epithelial-to-mesenchymal transition (EMT), a process crucially involved in tumor progression. The effects of the compound were determined in primary human keratinocytes, ex vivo skin explants, and the squamous carcinoma cell line A431. Our results demonstrate that URB597 is able to hinder the EMT process by downregulating mesenchymal markers and reducing migratory potential. These effects are associated with the dampening of the AKT/STAT3 signal pathways and reduced release of pro-inflammatory cytokines and tumorigenic lipid species. The ability of URB597 to contrast the EMT process provides insight into effective approaches that may also include the use of FAAH inhibitors for the treatment of skin cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
- Department of Plastic and Reconstructive Surgery, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
- Genetic Research, Molecular Biology and Dermatopathology Unit, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
ORCID-Profile: Enrica Flori, Emanuela Bastonini, Sarah Mosca, Emilia Migliano, Giorgia Cardinali
Förderung
- Ministero della Salute
- Italian Ministry of Health
Zitieren
APA
Kovacs, D., Flori, E., Bastonini, E., Mosca, S., Migliano, E., Cota, C., Zaccarini, M., Briganti, S., & Cardinali, G. (2023). Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417379
Vancouver
Kovacs D, Flori E, Bastonini E, Mosca S, Migliano E, Cota C, et al. Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417379
BibTeX
@article{Kovacs2023,
author = {Kovacs, Daniela and Flori, Enrica and Bastonini, Emanuela and Mosca, Sarah and Migliano, Emilia and Cota, Carlo and Zaccarini, Marco and Briganti, Stefania and Cardinali, Giorgia},
title = {Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417379}
}
EUVIMED